Product Name

  • Name

    Blood, exts.

  • EINECS
  • CAS No. 68070-90-6
  • Density
  • Solubility
  • Melting Point
  • Formula
  • Boiling Point
  • Molecular Weight 0
  • Flash Point
  • Transport Information
  • Appearance
  • Safety Poison by intravenous route. Moderately toxic by ingestion and subcutaneous routes. An experimental teratogen. Experimental reproductive effects.
  • Risk Codes
  • Molecular Structure Molecular Structure of 68070-90-6 (Blood, exts.)
  • Hazard Symbols
  • Synonyms
  • PSA
  • LogP

Deproteinized serum Chemical Properties

An extract from calf blood containing inorganic salts, amino acids, polypeptides and purines, but no proteins nor antigenic substances or blood group characteristics. Its exact composition is unknown. It has been proposed as a radiation-protective agent.
Product Name: Deproteinized serum
Synonyms of Deproteinized serum (CAS NO.68070-90-6): Blood, exts

Deproteinized serum Uses

 Deproteinized serum (CAS NO.68070-90-6) is often used as a rapid method for analysis of drugs and small molecules in serum in HPLC.

Deproteinized serum Toxicity Data With Reference

1.    

orl-rat LD50:1200 mg/kg

    KSRNAM    Kiso to Rinsho. Clinical Report. 7 (1973),2298.
2.    

scu-rat LD50:800 mg/kg

    KSRNAM    Kiso to Rinsho. Clinical Report. 7 (1973),2298.
3.    

ivn-rat LD50:400 mg/kg

    KSRNAM    Kiso to Rinsho. Clinical Report. 7 (1973),2298.
4.    

orl-mus LD50:4 g/kg

    KSRNAM    Kiso to Rinsho. Clinical Report. 7 (1973),2298.
5.    

scu-mus LD50:2 g/kg

    KSRNAM    Kiso to Rinsho. Clinical Report. 7 (1973),2298.
6.    

ivn-mus LD50:2 g/kg

    KSRNAM    Kiso to Rinsho. Clinical Report. 7 (1973),2298.

Deproteinized serum Safety Profile

Poison by intravenous route. Moderately toxic by ingestion and subcutaneous routes. An experimental teratogen. Experimental reproductive effects.

Deproteinized serum Specification

Reversed-phase liquid chromatography was investigated for the determination of anticonvulsants by direct injection of deproteinized serum (CAS NO.68070-90-6). Octyl modified silica (RP-8) as stationary phase and phosphate buffer (0.1M pH=3.0) — butanol 92∶8 (v/v) as mobile phase was found suitable for the simultaneous determination of primidone, phenobarbital, carbamazepine and diphenyl hydantoine directly in deproteinized sera from patients. Anticonvulsants like sulthiam, phenyl ethyl malondiamide, ethyl methyl succinimide and the epoxide metabolite of carbamazepine cannot be determined in this way because of disturbance by the serum background. It is shown that the analytical column can be used for on-column concentration of anticonvulsants with 1 cm3 deproteinized serum. The technique proved to be suitable for the determination of phenytoine-3-norvaline in serum.

Post buying leads

About|Contact|Cas|Product Name|Molecular|Country|Encyclopedia

Message|New Cas|MSDS|Service|Advertisement|CAS DataBase|Article Data|Manufacturers | Chemical Catalog

©2008 LookChem.com,License: ICP

NO.:Zhejiang16009103

complaints:service@lookchem.com Desktop View